Bryan P. Kwan

553 total citations
7 papers, 362 citations indexed

About

Bryan P. Kwan is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Bryan P. Kwan has authored 7 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Molecular Medicine. Recurrent topics in Bryan P. Kwan's work include Cancer therapeutics and mechanisms (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Bryan P. Kwan is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Bryan P. Kwan collaborates with scholars based in United States. Bryan P. Kwan's co-authors include Mark L. Cunningham, Karen Joy Shaw, John Finn, Kirk Nelson, Daniel C. Bensen, Michael Trzoss, M.T. Hilgers, Vickie Brown‐Driver, Junhu Zhang and Mark A. Stidham and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and The Journal of Antibiotics.

In The Last Decade

Bryan P. Kwan

7 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan P. Kwan United States 7 236 149 76 63 47 7 362
Pamela Hill United States 9 216 0.9× 112 0.8× 59 0.8× 31 0.5× 51 1.1× 11 349
Janelle Comita-Prevoir United States 9 192 0.8× 98 0.7× 120 1.6× 74 1.2× 31 0.7× 9 330
Jonathan D. Parsons United States 10 352 1.5× 133 0.9× 158 2.1× 68 1.1× 84 1.8× 10 480
Anthony Shillings United Kingdom 6 390 1.7× 117 0.8× 143 1.9× 121 1.9× 65 1.4× 7 498
Anne‐Laure Grillot United States 8 228 1.0× 168 1.1× 91 1.2× 42 0.7× 50 1.1× 10 338
Kenneth DenBleyker United States 9 138 0.6× 144 1.0× 55 0.7× 99 1.6× 15 0.3× 11 343
Tricia L. May‐Dracka United States 7 206 0.9× 97 0.7× 143 1.9× 105 1.7× 13 0.3× 7 451
John Breen United States 5 227 1.0× 107 0.7× 80 1.1× 52 0.8× 30 0.6× 6 327
Nishad Thamban Chandrika United States 12 191 0.8× 280 1.9× 54 0.7× 80 1.3× 23 0.5× 28 548
Marcus M. Maddox United States 10 183 0.8× 206 1.4× 25 0.3× 85 1.3× 22 0.5× 11 397

Countries citing papers authored by Bryan P. Kwan

Since Specialization
Citations

This map shows the geographic impact of Bryan P. Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan P. Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan P. Kwan more than expected).

Fields of papers citing papers by Bryan P. Kwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan P. Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan P. Kwan. The network helps show where Bryan P. Kwan may publish in the future.

Co-authorship network of co-authors of Bryan P. Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan P. Kwan. A scholar is included among the top collaborators of Bryan P. Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan P. Kwan. Bryan P. Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hilgers, M.T., Mark L. Cunningham, Bryan P. Kwan, et al.. (2014). Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines. Journal of Medicinal Chemistry. 57(3). 651–668. 66 indexed citations
2.
Hensler, Mary E., Kyoung Hwa Jang, Wdee Thienphrapa, et al.. (2014). Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus. The Journal of Antibiotics. 67(8). 549–553. 28 indexed citations
3.
Cunningham, Mark L., Bryan P. Kwan, Kirk Nelson, Daniel C. Bensen, & Karen Joy Shaw. (2013). Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay. SLAS DISCOVERY. 18(9). 1018–1026. 31 indexed citations
4.
Teng, Min, M.T. Hilgers, Mark L. Cunningham, et al.. (2013). Identification of Bacteria-Selective Threonyl-tRNA Synthetase Substrate Inhibitors by Structure-Based Design. Journal of Medicinal Chemistry. 56(4). 1748–1760. 41 indexed citations
5.
Bensen, Daniel C., Xiaoming Li, Zhiyong Chen, et al.. (2012). Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 23(5). 1537–1543. 58 indexed citations
6.
Tari, Leslie W., Michael Trzoss, Daniel C. Bensen, et al.. (2012). Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity. Bioorganic & Medicinal Chemistry Letters. 23(5). 1529–1536. 88 indexed citations
7.
Li, Xiaoming, M.T. Hilgers, Mark L. Cunningham, et al.. (2011). Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines. Bioorganic & Medicinal Chemistry Letters. 21(18). 5171–5176. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026